Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) versus chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer

Overview of attention for article published in Cochrane database of systematic reviews, April 2017

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 212 followers.

TPCH article contrib: Immune checkpoint inhibitors (anti PD-1 or anti PD-L1) versus chemotherapy for second...https://t.co/WPfuR4OjIL

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.